Innostem™, cardistem™ and cardiovastem™ are trademarks of Pharmahungary.
Pharmahungary Group is a preclinical (strong cardiovascular and metabolic platforms) and clinical (focusing on medical device and drug-device combination trials that need sensitive patient population, therefore, strong scientific and regulatory support) CRO with innovative in-house R&D projects open for out-licensing and/or co-development as well. Pharmahungary Group is currently focusing e.g. on the development of stem cell technology for cardiovascular research and development.